ESC Premium Access

Association between lowering heart rate during IMPELLA support and favorable short-term outcome in patients with cardiogenic shock

Congress Presentation

About the speaker

Doctor Kenji Maemura

Kitasato University School of Medicine, Kanagawa (Japan)
0 follower

32 more presentations in this session

Massive open online learning in basic life support and automated external defibrillation: an efficient way to improve confidence and readiness of lay people to provide help

Speaker: Associate Professor A. Birkun (Simferopol, RU)

Thumbnail

Barriers associated with emergency medical service activation in italian patients with ST-segment elevation acute coronary syndromes

Speaker: Doctor E. Baldi (Pavia, IT)

Thumbnail

Long-term prognostic factors of coronary artery disease patients after out-of-hospital cardiac arrest

Speaker: Doctor G. Nitta (Tokyo, JP)

Thumbnail

Effects of covid_19 pandemic on cardiac surgery and practice. Did we hit the mark: strategy or casuality ?

Speaker: Doctor A. Minotti (Rapallo, IT)

Thumbnail

Cardiac output monitoring using transthoracic echocardiography in children after cardiac surgery-an observational study of feasibility and concordance with transpulmonary thermodilution

Speaker: Doctor S. Guha Niyogi (Chandigarh, IN)

Thumbnail

Access the full session

Acute Cardiac Care ePosters

Speakers: Doctor K. Maemura, Associate Professor A. Birkun, Doctor E. Baldi, Doctor G. Nitta, Doctor A. Minotti...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Acute myocardial infarction with cardiogenic shock: how I did treat.

29 August 2021

ESC Premium Access

Prognostic significance of different congestion evaluation modalities in acute heart failure patients classified according to left ventricular ejection fraction

28 August 2021

ESC Premium Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk